等待开盘 11-18 09:30:00 美东时间
-0.120
-4.21%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # SIGA Technologies 业绩回顾摘要(截至2026年9月30日第三季度及前九个月) ## 1. 财务业绩 **第三季度业绩:** - 总营收:130万美元,较上年同期的260万美元下降 - 产品销售收入:233,689美元,较上年同期的889,748美元大幅下降(本季度无客户交付) - 研发收入:110万美元,较2025年第三季度的170万美元下降 - 税前经营亏损:约700万美元 - 净亏损:290万美元,较上年同期的640万美元净亏损收窄 - 摊薄每股亏损:0.04美元,较上年同期的每股亏损0.09美元改善 **前九个月业绩:**
11-10 13:05
SIGA Technologies (NASDAQ:SIGA) reported quarterly losses of $(0.04) per share. This is a 55.56 percent increase over losses of $(0.09) per share from the same period last year. The company reported $1.317 million in sales this quarter. This is a 49.73 percent decrease over sales of $2.620 million t...
11-10 05:03
SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that Public Services and Procurement Canada (PSPC) has awarded SIGA a new contract for the procurement of oral TPOXX® (tecovirimat), an antiviral medication used to treat smallpox, on behalf of ...
10-28 19:32
SIGA Technologies has been awarded a $15 million contract by Public Services and Procurement Canada (PSPC) to supply oral TPOXX® for the Canadian Armed Forces. This is the second contract awarded by PSPC on behalf of the Canadian Department of National Defence (CDND), with the first completed in 2025. The agreement underscores Canada's commitment to smallpox preparedness and aligns with its health security objectives. TPOXX®, approved by Health C...
10-28 11:30
SIGA Technologies (NASDAQ:SIGA) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. Access the full ca...
10-12 20:28
SIGA Technologies, Inc. (SIGA) will host a webcast and conference call on August 6, 2026, at 4:30 P.M. ET, featuring CEO Diem Nguyen and CFO Daniel Luckshire, to discuss business updates. The live webcast and replay will be available on SIGA's website, and participants can join via phone using the provided numbers. SIGA is a pharmaceutical company focused on developing innovative medicines to combat infectious diseases, particularly orthopoxvirus...
07-30 11:30
SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from the European Patent Office targeting 5-HT4.
04-07 17:20
SIGA Technologies Inc. (NASDAQ: SIGA) shares are trading higher Friday after the company declared a special cash dividend of $0.60 per share.
03-28 00:40
The European Medicines Agency announced on Friday that an expert panel of the drug regulator has recommended that tecovirimat, an antiviral developed by SIGA Technologies (SIGA), should no longer be u...
03-27 21:21
SIGA Technologies ( ($SIGA) ) has issued an announcement. On March 26, 2026, SI...
03-27 04:44